172 related articles for article (PubMed ID: 35953108)
1. Parathyroid hormone-related protein (PTHrP) and malignancy.
Grunbaum A; Kremer R
Vitam Horm; 2022; 120():133-177. PubMed ID: 35953108
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
Bundred NJ; Walls J; Ratcliffe WA
Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone-related protein in tumor tissues obtained from patients with humoral hypercalcemia of malignancy.
Tsuchihashi T; Yamaguchi K; Miyake Y; Otsubo K; Nagasaki K; Honda S; Akiyama Y; Maeda Y; Koike M; Alper O
J Natl Cancer Inst; 1990 Jan; 82(1):40-4. PubMed ID: 2293655
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone related protein (PTHrP) in tumor progression.
Kremer R; Li J; Camirand A; Karaplis AC
Adv Exp Med Biol; 2011; 720():145-60. PubMed ID: 21901625
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia in cancer.
Martin TJ; Grill V
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):123-9. PubMed ID: 1525053
[TBL] [Abstract][Full Text] [Related]
8. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
9. Incidence of humoral hypercalcemia of malignancy among hypercalcemic patients with cancer.
Szymanski JJ; Otrock ZK; Patel KK; Scott MG
Clin Chim Acta; 2016 Jan; 453():190-3. PubMed ID: 26706788
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates.
Mills TA; Orloff M; Domingo-Vidal M; Cotzia P; Birbe RC; Draganova-Tacheva R; Martinez Cantarin MP; Tuluc M; Martinez-Outschoorn U
Semin Oncol; 2015 Dec; 42(6):909-14. PubMed ID: 26615135
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid Hormone-Related Protein (PTHrP): An Emerging Target in Cancer Progression and Metastasis.
Zhang R; Li J; Assaker G; Camirand A; Sabri S; Karaplis AC; Kremer R
Adv Exp Med Biol; 2019; 1164():161-178. PubMed ID: 31576548
[TBL] [Abstract][Full Text] [Related]
12. Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells.
Mamillapalli R; VanHouten J; Zawalich W; Wysolmerski J
J Biol Chem; 2008 Sep; 283(36):24435-47. PubMed ID: 18621740
[TBL] [Abstract][Full Text] [Related]
13. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
15. Circulating parathyroid hormone-related protein (109-141) in malignancy-associated hypercalcemia.
Nagasaki K; Otsubo K; Kajimura N; Tanaka R; Watanabe H; Tachimori Y; Kato H; Yamaguchi H; Saito D; Watanabe T; Adachi I; Yamaguchi K
Jpn J Clin Oncol; 1996 Feb; 26(1):6-11. PubMed ID: 8551669
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein in breast cancer bone metastasis.
Johnson RW; Rhoades J; Martin TJ
Vitam Horm; 2022; 120():215-230. PubMed ID: 35953110
[TBL] [Abstract][Full Text] [Related]
17. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic hypercalcemia in a patient with adenosquamous cancer of the colon.
Thompson JT; Paschold EH; Levine EA
Am Surg; 2001 Jun; 67(6):585-8. PubMed ID: 11409809
[TBL] [Abstract][Full Text] [Related]
20. The humoral hypercalcemia of benignancy. A newly appreciated syndrome.
Knecht TP; Behling CA; Burton DW; Glass CK; Deftos LJ
Am J Clin Pathol; 1996 Apr; 105(4):487-92. PubMed ID: 8604692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
